Tenet Healthcare Corporation THC
290.27 USD +1.27 (+0.44%)
At closeNov 10, 2026, 4:00 PM EST
293.00 +2.73 +0.94%
After hours · Nov 10, 4:00 PM ET
286.12 Day range 292.32
157.58 52-week range 301.44
- YTD
- +46.07%
- 1 year
- +49.10%
News
zacks.com Here's Why Tenet Healthcare (THC) is a Strong Growth Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
247wallst.com Hospital Stocks Soared as Democrats Took Congress HCA posted its biggest one-day jump in four years before a single law changed. Wall Street is pricing in relief that needs Congress, a presidential signature, and a December funding fight to survive.
benzinga.com Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $297 Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $271 to $297.
barrons.com Healthcare Stocks Bounce on Midterm Results. A Bull Market Case Is Developing. The stocks of big operators in state Medicaid programs, Affordable Care Act markets and hospital groups all jumped.
zacks.com Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
benzinga.com Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $305 Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $290 to $305.- benzinga.com Keybanc Maintains Overweight on Tenet Healthcare, Raises Price Target to $300 Keybanc analyst Matthew Gillmor maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $270 to $300.
- benzinga.com Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342 Leerink Partners analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $309 to $342.
benzinga.com RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $304 RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $283 to $304.- benzinga.com Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321 Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $281 to $321.
benzinga.com Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $306 Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $307 to $306.
benzinga.com Tenet Healthcare Q3 2026 Earnings Call Transcript Tenet Healthcare (NYSE:THC) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Tenet Healthcare Raises FY2026 Adj EPS Guidance from $20.30-$21.69 to $22.05-$23.01 vs $21.01 Est; Narrows FY2026 Sales Guidance from $21.900B-$22.500B to $22.050B-$22.450B vs $22.351B Est Tenet Healthcare (NYSE:THC) raises FY2026 Adj EPS guidance from $20.30-$21.69 to $22.05-$23.01 vs $21.01 analyst estimate. Narrows FY2026 sales outlook from $21.900 billion-$22.500 billion to $22.050…- benzinga.com Tenet Healthcare Raises FY2026 GAAP EPS Guidance from $34.57-$36.43 to $35.82-$37.08 vs $33.03 Est Tenet Healthcare (NYSE:THC) raises FY2026 GAAP EPS guidance from $34.57-$36.43 to $35.82-$37.08 vs $33.03 analyst estimate..
- benzinga.com Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $307 Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $283 to $307.